The Toronto Stock Exchange reports that Eupraxia Pharmaceuticals Inc. common share purchase warrants will expire at 5 p.m. Toronto time on March 9, 2026, and will be delisted at the close on the same day. According to the TSX, each warrant entitles the holder to acquire a common share of the company at $11.20 per share until its expiry. Trades from the open to 12 p.m. Toronto time on March 9, 2026, will settle on the same day.